Clinical Trial

Preterm Birth Cohort Study in Guangzhou

Study acronym: PBCSG
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 26, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The Preterm Birth Cohort Study in Guangzhou (PBCSG) aims to explore the impact of genetic and environmental factors including life styles on preterm birth, to examine the interaction effect between these factors, and to follow up the short-term and long-term outcomes of preterm childrens.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2018-09-10; most recent amendment 2024-02-22.
Trial Details
NCT Number NCT03668327
Lead Sponsor Guangzhou Women and Children's Medical Center
Conditions Preterm Birth, Neurodevelopment, Immune Development, Host and Microbiome
Enrollment 5,000 participants
Start Date 2012-02-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2038-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-26